1. Home
  2. HUN vs RLAY Comparison

HUN vs RLAY Comparison

Compare HUN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huntsman Corporation

HUN

Huntsman Corporation

HOLD

Current Price

$15.10

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$12.77

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUN
RLAY
Founded
1970
2015
Country
United States
United States
Employees
6300
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.5B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
HUN
RLAY
Price
$15.10
$12.77
Analyst Decision
Hold
Strong Buy
Analyst Count
11
10
Target Price
$12.09
$19.50
AVG Volume (30 Days)
4.9M
3.1M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
2.64%
N/A
EPS Growth
N/A
31.78
EPS
N/A
N/A
Revenue
$5,683,000,000.00
$15,355,000.00
Revenue This Year
$3.08
N/A
Revenue Next Year
$5.27
$324.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.44
52 Week Low
$7.30
$2.71
52 Week High
$15.90
$17.32

Technical Indicators

Market Signals
Indicator
HUN
RLAY
Relative Strength Index (RSI) 66.14 45.12
Support Level $13.10 $6.67
Resistance Level N/A $17.32
Average True Range (ATR) 0.76 1.02
MACD 0.10 -0.47
Stochastic Oscillator 72.01 19.21

Price Performance

Historical Comparison
HUN
RLAY

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: